https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2213525
Jan 22, 2024 - The FDA concludes the reinspection of Alvotech's (ALVO) facility in Iceland. The company believes that it may receive approval for biosimilar candidates, AVT02 and AVT04, in the United States. Stock rises.
zc:-1068902512350927246
0
https://www.zacks.com/stock/news/2214454/hilton-hlt-reports-solid-2023-unit-growth-signings-up-y-y?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2214454
Jan 23, 2024 - Hilton (HLT) anticipates a favorable trajectory in 2024 net unit growth, backed by robust signings and construction starts. Also, the addition of Spark by Hilton and LivSmart Studios bodes well.
zc:-1850696865529130107
0
https://www.zacks.com/stock/news/2214384/gear-up-for-gentex-gntx-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2214384
Jan 23, 2024 - Get a deeper insight into the potential performance of Gentex (GNTX) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:-5544403823803240078
0
https://www.zacks.com/stock/news/2214410/gartner-it-is-up-2-35-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2214410
Jan 23, 2024 - Does Gartner (IT) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-6472270968947112522
0
https://www.zacks.com/stock/news/2214322/procter-gamble-pg-beats-q2-earnings-estimates-ups-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2214322
Jan 23, 2024 - Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
zc:191133150148406741
0
https://www.zacks.com/stock/news/2214343/ups-gears-up-to-release-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2214343
Jan 23, 2024 - UPS fourth-quarter 2023 results are likely to gain from falling expenses.
zc:-8581546398093900354
0
https://www.zacks.com/stock/news/2215183/dell-technologies-dell-is-up-4-89-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2215183
Jan 24, 2024 - Does Dell Technologies (DELL) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:9096130006312630792
0
https://www.zacks.com/stock/news/2215086/nvr-gears-up-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2215086
Jan 24, 2024 - NVR's fourth-quarter 2023 results are quite likely to reflect high mortgage rates and reduced new homes settlements.
zc:-7563908525657611068
0
https://www.zacks.com/stock/news/2215206/amphenol-s-aph-q4-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2215206
Jan 24, 2024 - Amphenol's (APH) Q4 results benefit from higher revenues across the commercial air, defense, automotive and IT datacom end-markets.
zc:-8364468869222079815
0
https://www.zacks.com/stock/news/2215911/northrop-s-noc-q4-earnings-beat-estimates-sales-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2215911
Jan 25, 2024 - Northrop Grumman's (NOC) Q4 earnings and sales surpass estimates. The company holds a solid order backlog and issues strong 2024 sales guidance.
zc:7231632959654767311
0